Atlas Trials

Glofitamab Bridging ASCT for Patients With Relapsed or Refractory DLBCL

Clinical trial NCT06682130 · RECRUITING

Trial details

NCT number
NCT06682130
Sponsor
The First Affiliated Hospital of Soochow University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Diffuse Large B-cell Lymphoma(DLBCL)
Start date
2024-11-10
Primary completion
2027-11-10
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.